Aspire Biopharma Holdings, Inc. (ASBP) vs Sunshine Biopharma, Inc. (SBFM)
A side-by-side comparison of Aspire Biopharma Holdings, Inc. and Sunshine Biopharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ASBP
Aspire Biopharma Holdings, Inc.
$8.94HealthcareDelayed quote: Oct 6, 2026, 12:59 PM EDT
SBFM
Sunshine Biopharma, Inc.
$0.37HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
Total return — ASBP vs SBFM
growth of $100 · dividends reinvested · last 4yASBP -99.9% (-85.0%/yr)SBFM -100.0% (-92.4%/yr)ASBP compounded faster over this window
Log scale — wide-divergence pair
ASBP SBFM
ASBP vs SBFM: by the numbers
- •ASBP is the larger company ($1M vs $880215 market cap).
- •Both run net losses; SBFM's is the smaller (-16.50% vs -11314.24% net margin).
Metrics side by side
Valuation
| Metric | ASBP | SBFM |
|---|---|---|
| P/S ratio | 10.56 | 0.02 |
| P/B ratio | 0.09 | 0.03 |
Profitability
| Metric | ASBP | SBFM |
|---|---|---|
| Gross margin | -1.87% | 29.80% |
| Operating margin | -312016.95% | -14.71% |
| Net margin | -11314.24% | -16.50% |
| ROE | -93.97% | -21.18% |
| ROIC | -59.81% | -18.56% |
Growth (annualized)
| Metric | ASBP | SBFM |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 203.18% |
Go deeper
Dig into the metrics
Aspire Biopharma ROESunshine Biopharma ROEAspire Biopharma operating marginSunshine Biopharma operating marginAspire Biopharma revenue growthSunshine Biopharma revenue growthAspire Biopharma free cash flowSunshine Biopharma free cash flow
Aspire Biopharma & Sunshine Biopharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.